摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(rac)-(2R,4aS,5R,8aS)-5-methyl-2-propyl-decahydroquinoline | 106565-72-4

中文名称
——
中文别名
——
英文名称
(rac)-(2R,4aS,5R,8aS)-5-methyl-2-propyl-decahydroquinoline
英文别名
(2R,4aS,5R,8aS)-Decahydro-5-methyl-2-propylquinoline;(2R,4aS,5R,8aS)-5-methyl-2-propyl-1,2,3,4,4a,5,6,7,8,8a-decahydroquinoline
(rac)-(2R,4aS,5R,8aS)-5-methyl-2-propyl-decahydroquinoline化学式
CAS
106565-72-4
化学式
C13H25N
mdl
——
分子量
195.348
InChiKey
PSGDYNNBBROEEW-NDBYEHHHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    261.4±8.0 °C(Predicted)
  • 密度:
    0.854±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    12
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    (rac)-(2R,4aS,5R,8aS)-5-methyl-2-propyl-decahydroquinoline4-硝基苯甲酰氯三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 3.0h, 以83%的产率得到(rac)-[(2R,4aS,5R,8aS)-5-methyl-2-propyl-octahydroquinoline-1-yl]-(4-nitrophenyl)-methanone
    参考文献:
    名称:
    环重排复分解和锆介导的环化非对映选择性合成2,5-二取代十氢喹啉
    摘要:
    描述了通过锆介导的不饱和 a,a'-二取代哌啶 II 环化对 2,5-取代十氢喹啉的非对映选择性方法。所需的哌啶可以通过钌催化的环重排复分解 (RRM) 从仲磺酰胺 III 中以高收率获得。外消旋 trans-195A 和 2-epi-trans-195A 从丁醛和 cyclohex-2-enol 开始分 8 步合成。
    DOI:
    10.1055/s-2004-834904
  • 作为产物:
    描述:
    5-氯-2-戊酮 在 palladium on activated charcoal aluminum oxide 、 sodium tetrahydroborate 、 氢气sodium 作用下, 以 盐酸甲醇二氯甲烷 为溶剂, 反应 35.0h, 生成 (rac)-(2R,4aS,5R,8aS)-5-methyl-2-propyl-decahydroquinoline
    参考文献:
    名称:
    2-氰基Δ 3个piperideines VIII:仿生方法的十氢喹啉环系的合成毒镖蛙毒素
    摘要:
    已经开发了仿生方法来合成pumiliotoxinC。通过与氧化铝接触催化烯胺当量为8至9的关键转化。然后将环化的中间体9立体选择性地还原为反式十氢喹啉11或立体选择性地还原为顺式化合物12。
    DOI:
    10.1016/s0040-4039(00)81690-1
点击查看最新优质反应信息

文献信息

  • Asymmetric synthesis VIII: Biogenetically patterned approach to the chiral total synthesis of (−)-pumiliotoxin-C
    作者:M Bonin、J Royer、D.S Grierson、H.-P Husson
    DOI:10.1016/s0040-4039(00)84315-4
    日期:1986.1
    (−)-Pumiliotoxin-C and the (+)-9,10- isomer were prepared in six steps from the chiral (+)-2-cyano-6-oxazolopiperidine synthon .
    (-)-Pumiliotoxin-C和(+)-9,10-异构体是从手性(+)-2-cyano-6-oxazolopiperidine合成子中分六步制备的。
  • Husson, Henri-Philippe, Bulletin des Societes Chimiques Belges, 1982, vol. 91, # 12, p. 985 - 996
    作者:Husson, Henri-Philippe
    DOI:——
    日期:——
  • Diastereoselective Synthesis of 2,5-Disubstituted Decahydroquinolines via Ring-Rearrangement Metathesis and Zirconium-Mediated Cyclization
    作者:Siegfried Blechert、Jürgen Neidhöfer
    DOI:10.1055/s-2004-834904
    日期:——
    zirconium-mediated cyclization of unsaturated a,a'-disubstituted piperidines II is described. The required piperidines could be obtained from secondary sulfonamides III via ruthenium-catalyzed ring-rearrangement metathesis (RRM) in high yields. Racemic trans-195A and 2-epi-trans-195A were synthesized in 8 steps starting with butyraldehyde and cyclohex-2-enol.
    描述了通过锆介导的不饱和 a,a'-二取代哌啶 II 环化对 2,5-取代十氢喹啉的非对映选择性方法。所需的哌啶可以通过钌催化的环重排复分解 (RRM) 从仲磺酰胺 III 中以高收率获得。外消旋 trans-195A 和 2-epi-trans-195A 从丁醛和 cyclohex-2-enol 开始分 8 步合成。
  • 2-Cyano Δ3 piperideines VIII : Biomimetic approach to the synthesis of the decahydroquinoline ring system of poison-dart frog toxins
    作者:M. Bonin、R. Besselièvre、D.S. Grierson、H.-P. Husson
    DOI:10.1016/s0040-4039(00)81690-1
    日期:——
    A biomimetic approach towards the synthesis of pumiliotoxin C has been developed. The key transformation of enamine equivalent 8 to 9 was catalyzed by contact with alumina. Cyclized intermediate 9 was then reduced stereospecifically to the trans decahydroquinoline 11 or stereoselectively to the cis compound 12.
    已经开发了仿生方法来合成pumiliotoxinC。通过与氧化铝接触催化烯胺当量为8至9的关键转化。然后将环化的中间体9立体选择性地还原为反式十氢喹啉11或立体选择性地还原为顺式化合物12。
查看更多

同类化合物

锯齿石松宁 箭毒蛙毒素 C 坎库碘铵 十氢喹啉 十氢-2-甲基喹啉 八氢对苯二酚-4(1H)-酮 八氢喹啉-2(1H)-酮 八氢-2,6-喹啉二酮 [(4aS,4bR,6aS,8S,10aS,10bS,12aS)-10a,12a-二甲基-1,2,3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十六氢萘并[6,5-f]喹啉-8-基]2-[4-[二(2-氯乙基)氨基]苯基]乙酸酯 [(4aS,4bR,6aS,8S,10aS,10bS,12aS)-1,10a,12a-三甲基-2-氧代-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十四氢萘并[6,5-f]喹啉-8-基]2-[4-[二(2-氯乙基)氨基]苯基]乙酸酯 8H-13,3,6a-乙基亚基-7,10-亚甲基噁庚并[3,4-i]-1-苯并吖辛因-8-酮,1-乙基十四氢-12a-羟基-6-甲氧基-3-甲基-,(3R,6S,6aS,7R,7aS,10S,12aS,13S,13aR,15R)-(9CI) 8-羟基-十氢喹啉 4-乙炔基-2-甲基十氢喹啉-4-醇 3-羟基-13,17-开环-5-雄甾烯-17-酸-13,17-内酰胺(4-(二(2-氯乙基)氨基)苯基)丁酸酯 2,5-二丙基十氢喹啉 1-(3-氯-丙基)-十氢-喹啉 1,2,2-三甲基-八氢-喹啉-4-酮 (4aS,4bR,8S,10aR,10bS,12aS)-10a,12a-二甲基-2-羰基-1,2,3,4,4a,4b,5,7,8,9,10,10a,10b,11,12,12a-十六氢萘并[2,1-f]喹啉-8-基{4-[二(2-氯乙基)氨基]苯基}乙酸酯 (4aS,4bR,6aS,8S,10aS,10bS,12aS)-8-羟基-10a,12a-二甲基-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十四氢-1H-萘并[2,1-f]喹啉-2-酮 (3S,13R)-1,2,3,4,4aalpha,5,11,11aalpha-八氢-2,2,5-三甲基-3beta,5beta-乙桥-10bH-吡啶并[3,2-b]咔唑-10bbeta,13-二醇 (3R,6S,6aS,7R,7aS,10S,12aS,13R,13aR,14S,15R)-1-乙基十四氢-12a,14-二羟基-6-甲氧基-3-甲基-8H-13,3,6a-亚乙基-7,10-甲桥氧杂卓并[3,4-i]-1-苯并氮杂环辛四烯-8-酮 (2S,4aR,8aR)-2-甲基八氢-4(1H)-喹啉酮 (2R,4R,4As,8As)-rel-4-乙炔基十氢-1,2-二甲基-4-喹啉醇 (4aS,5R,8aR)-1-(tert-butoxy)carbonyl-2-oxo-5-(triisopropylsilyloxymethyl)decahydroquinoline trans-(+/-)-1-n-propyl-7-oxodecahydroquinoline 3,4,5,6,6a,7,8,9,10,10a-decahydro-(4aβH)-benzo[c]quinolizin-3-one 3,4,5,6,6a,7,8,9,10,10a-decahydro-(4aαH)-benzo[c]quinolizin-3-one 3,4,4a,5,6,7,8-heptahydro-8a-hydrodioxy-2(1H)-quinolinone [2-(2,3-dichloro-phenyl)-thiazol-4-yl]-(octahydro-quinolin-1-yl)-methanone (octahydro-quinolin-1-yl)-(2-pyridin-3-yl-thiazol-4-yl)-methanone 2-methylperhydrothiazolo<2,3-j>quinoline 2,4-dichloro-N-[5-((4aRS,8aSR)-octahydroquinoline-1-carbonyl)pyridin-2-yl]benzamide (4aR*,5S*,8aR*)-1,2,3,4,4a,5,6,7,8,8a-Decahydro-5-<(dimethylphenylsilyl)methyl>-1-methylquinoline (4aS*,5S*,8aR*)-1,2,3,4,4a,5,6,7,8,8a-Decahydro-5-<(dimethylphenylsilyl)methyl>-1-(methoxycarbonyl)quinoline (2S,3R,4aS,5R,8aR)-1-(tert-butoxy)carbonyl-3-hydroxy-2-methyl-5-(triisopropylsilyloxymethyl)decahydroquinoline (+/-)-(2SR,4aRS,8aRS)-1-tert-butyloxycarbonyl-5-methylene-2-propyldecahydroquinoline (+/-)-(2SR,4aRS,8aRS)-1-tert-butyloxycarbonyl-2-propyldecahydroquinolin-5-one cis-4-[4-(octahydro-quinoline-1(2H)-ylcarbonyl)-thiophen-2-yl]-piperidine-1-carboxylic acid amide lepadin E (+)-lepadin D cis-(octahydro-quinolin-1(2H)-yl)-(5-piperidin-4-yl-thiophen-3-yl)-methanone 4-methyl-6-(3-methyl-2-thienyl)-4,5,6,7-tetrahydroquinolin-5-one 2,2,4,8-tetramethyldecahydroquinoline 10-oxo-2,5;5,9-diseco-A-dinor-strychnidine-2,5-dioic acid strychnidine-2,3,10-trione 3-tetrazolo-17a-aza-D-homo-3,5-androstadien-17-one 17a-methyl-3-tetrazolo-17a-aza-D-homo-3,5-androstadien-17-one methyl 4-oxooctahydroquinoline-1(2H)-carboxylate decahydro-2-oxo-8-quinolinepropanoic acid ethyl ester 1-octahydro[1]quinolyl-propan-2-ol